<DOC>
	<DOCNO>NCT01114152</DOCNO>
	<brief_summary>This Phase I randomize double-blind , placebo-controlled , single multiple ascend dose study assess safety , tolerability pharmacokinetics AZD9742 healthy male female Japanese subject</brief_summary>
	<brief_title>AZD9742 Single Multiple Ascending Dose Study Healthy Male Female Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>female ( nonchildbearing potential ) Body mass index ( BMI ) : 17 27 kg/m 2 History clinically significant disease disorder , opinion Investigator , may either put subject risk participation study , influence result subject 's ability participate study History presence gastrointestinal , hepatic , renal disease otherHistory presence gastrointestinal , hepatic , renal disease condition know interfere absorption , distribution , metabolism , excretion drug Any clinically significant illness , medical/surgical procedure , trauma within 4 week first administration investigational product</criteria>
	<gender>All</gender>
	<minimum_age>23 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>AZD9742</keyword>
	<keyword>Japanese Healthy Volunteers</keyword>
	<keyword>Phase I</keyword>
	<keyword>Single Multiple Ascending Dose</keyword>
</DOC>